Jacqueline S. Jeruss,Virginia Kaklamani,Shreyas S. Rao
申请号：
US14968711
公开号：
US20160166536A1
申请日:
2015.12.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Pharmaceutical compositions and methods of inhibiting tumor cell proliferation of triple-negative (ER−/PR−/HER2−) breast cancer cells and for treating subjects with a form of breast cancer having a triple-negative (ER−/PR−/HER2−) phenotype are provided. The methods include a step of contacting triple-negative breast cancer cells with an effective amount of a composition including Eribulin and CYC065.
